In the latest trading session, 1.25 million Opko Health Inc (NASDAQ:OPK) shares changed hands as the company’s beta touched 1.64. With the company’s most recent per share price at $1.50 changed hands at -$0.02 or -1.64% at last look, the market valuation stands at $1.04B. OPK’s current price is a discount, trading about -16.67% off its 52-week high of $1.75. The share price had its 52-week low at $0.85, which suggests the last value was 43.33% up since then. When we look at Opko Health Inc’s average trading volume, we note the 10-day average is 4.25 million shares, with the 3-month average coming to 3.37 million.

Analysts gave the Opko Health Inc (OPK) stock a consensus recommendation rating of Hold, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 6 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 4 recommended OPK as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Opko Health Inc’s EPS for the current quarter is expected to be -0.09.

Opko Health Inc (NASDAQ:OPK) trade information

Instantly OPK was in red as seen in intraday trades today. With action -0.33%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -0.99%, with the 5-day performance at -0.33% in the red. However, in the 30-day time frame, Opko Health Inc (NASDAQ:OPK) is -5.97% down. Looking at the short shares, we see there were 98.23 million shares sold at short interest cover period of 32.82 days.

The consensus price target for the stock as assigned by Wall Street analysts is 3.5, meaning bulls need an upside of 57.14% from its recent market value. According to analyst projections, OPK’s forecast low is 3 with 4 as the target high. To hit the forecast high, the stock’s price needs a -166.67% plunge from its current level, while the stock would need to soar -100.0% for it to hit the projected low.

Opko Health Inc (OPK) estimates and forecasts

Data shows that the Opko Health Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 14.12% over the past 6 months, a -16.00% in annual growth rate that is considerably lower than the industry average of 13.40%. Year-over-year growth is forecast to reach -18.30% down from the last financial year.

Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of 181.52M. 6 analysts are of the opinion that Opko Health Inc’s revenue for the current quarter will be 167.82M. The company’s revenue for the corresponding quarters a year ago was 178.6M and 181.9M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 1.60%. The estimates for the next quarter sales put growth at -7.70%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 1.56%. The 2024 estimates are for Opko Health Inc earnings to decrease by -20.67%, but the outlook for the next 5-year period is at 12.00% per year.

OPK Dividends

Opko Health Inc is expected to release its next quarterly earnings report on 2024-Nov-04.

Opko Health Inc (NASDAQ:OPK)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 53.23% of Opko Health Inc shares while 27.11% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 57.96%. There are 27.11% institutions holding the Opko Health Inc stock share, with RUBRIC CAPITAL MANAGEMENT LP the top institutional holder. As of 2024-06-30, the company held 6.2843% of the shares, roughly 44.42 million OPK shares worth $55.53 million.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 4.1373% or 29.25 million shares worth $36.56 million as of 2024-06-30.